RSS-Feed abonnieren
DOI: 10.1055/s-2002-33102
© Georg Thieme Verlag Stuttgart · New York
Does Cardiopulmonary Bypass Alter Plasma Level of Tumor Markers? CA 125 and Carcinoembryonic Antigen
Publikationsverlauf
Publikationsdatum:
07. August 2002 (online)
![](https://www.thieme-connect.de/media/thoracic/200204/lookinside/thumbnails/10.1055-s-2002-33102-1.jpg)
Abstract
Background: In addition to malignant diseases, acute and chronic inflammations may elevate plasma levels of tumor markers CA 125 and carcinoembryonic antigen (CEA). Cardiopulmonary bypass (CPB) causes a generalized inflammatory response. In this study, we have investigated the effect of CPB on plasma levels of CA 125 and CEA. Methods: We measured plasma levels of CA 125 and CEA in patients undergoing coronary artery bypass grafting (CABG) with CPB (Group 1, n = 21), and in patients who underwent off-pump CABG, that is, without CPB (Group 2, n = 16). Blood samples were collected preoperatively, and on postoperative days 1, 6, and 12. Results: Within both groups, CEA plasma levels were not significantly influenced in any samples. Comparing with preoperative values, CA 125 values elevated significantly on postoperative days 6 and 12 within both groups. It was observed that the elevation of CA 125 plasma levels in these samples were significantly higher in Group 1. Conclusions: The results indicate that CPB elevated plasma level of CA 125. However, clinical importance of this finding needed further evaluation.
Key words
Cardiopulmonary bypass - Tumor markers - Coronary artery bypass surgery
References
- 1 Duffy M J. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci. 2001; 38 225-262
- 2 Kao C Y, Liaw C C, Chen T C. Tuberculosis presenting with pelvic mass, peritoneal lesions, and elevation of serum CA125 mimicking malignant tumor: a case report. Changeng Yi Xue Za Zhi. 2000; 23 230-234
- 3 Le Thi Huong D U, Mohattane H, Piette J C. et al . Specificity of CA 125 tumor marker. A study of 328 cases of internal medicine. Presse Med. 1988; 17 (43) 2287-2291
- 4 Nagele H, Bahlo M, Klapdor R, Rodiger W. Fluctuations of tumor markers in heart failure patients pre and post heart transplantation. Anticancer Res. 1999; 19 2531-2534
- 5 Nagele H, Bahlo M, Klapdor R, Schaeperkoetter D, Rodiger W. CA 125 and its relation to cardiac function. Am Heart J. 1999; 134 (6) 1044-1049
- 6 Cacoub P, Le Thi H D, Wechsler B. et al . Chronic constrictive pericarditis responsible for an increase of CA 125 levels. Two cases. Presse Med. 1990; 19 (37) 1712-1714
- 7 Ruibal Morell A. CEA serum levels in non-neoplastic disease. In J Biol Markers. 1992; 7 (3) 160-166
- 8 Koh K K, In H H, Lee K H. et al . New scoring system using tumor markers in diagnosing patients with moderate pericardial effusions. In J Cardiol. 1997; 61 (1) 5-13
- 9 Nguyen D M, Mulder D S, Shennib H. Effect of Cardiopulmonary Bypass on Circulating Lymphocyte Function. Ann Thorac Surg. 1992; 53 611-616
- 10 Diegeler A, Tarnok A, Rauch T. et al . Changes of Leukocyte Subsets in Coronary Artery Bypass Surgery: Cardiopulmonary Bypass Versus “Off-pump” techniques. Thorac Cardiovasc Surg. 1998; 46 327-332
- 11 Bruins P, Velthuis H, Yazdanbakhsh A P. et al . Activation of the Complement System During and After Cardiopulmonary Bypass Surgery. Circulation. 1997; 96 3542-3548
- 12 Fransen E J, Maessen J G, Hermens W T, Glatz J FC, Buurman W A. Peri-operative myocardial tissue injury and the release of inflammatory mediators in coronary artery bypass graft patients. Cardiovascular Research. 2000; 45 853-859
- 13 Jansen N JG, Oeveren W, Vliet M, Stoutenbeek C P, Eysman L, Wildevuur C RH. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J Cardio-thorac Syrg. 1991; 5 211-217
- 14 Kirklin J K, Westaby S, Blackstone E H, Kirklin J W, Chenoweth D E, Pacifico A D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983; 86 845-857
- 15 Bates S E. Clinical applications of serum tumor markers. Ann Intern Med. 1991; 115 623-638
- 16 Downing S W, Edmunds L. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg. 1992; 54 1236-1243
- 17 Westaby S. Organ dysfunction after cardiopulmonar bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med. 1987; 13 89-95
MD Bektas Battaloglu
Inonu University, Turgut Ozal Medical Center, Dept. of Cardiovascular Surgery
44069 Malatya
Taipei, Taiwan
Turkey
Telefon: +90 (422) 341 06 60
Fax: +90 (422) 341 07 28
eMail: bebat@superonline.com